Playing it Cool

With pharma investing heavily in cell-based research and drug development, it is becoming imperative to take extra precautions in maintaining temperature stability. Although recognition is widespread, efforts to standardize processes are still in their early days. However, the technology involved with controlled-rate cell freezing has seen significant updates in recent years.

 

Fill out the form to download the full article and learn more about the innovative temperature standardization solutions supporting pharma research!

 

Playing it Cool

 

Complete the form to download the publication

I acknowledge I will receive communications about Brooks Life Sciences, including service/product updates, new technology developments, and promotions.

No, I would not like to receive these communications from Brooks Life Sciences.

 

Brooks Life Sciences does not share or sell your information. Read our Privacy Policy. Email preferences can be updated at any time.